Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsIndustry lead sponsorIndustry collaboratorPhase 2

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

lenalidomide / Generic mfg.

LENAMAINT, NCT00720850 / 2007-002433-37: Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Terminated

Europe

lenalidomide, Revlimid

Technische Universität Dresden, Celgene Corporation

Myelodysplastic Syndromes, Acute Myelogenous Leukemia

01/11

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites